Hot Features
Premium
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Nom Action | Symbole Action | Marché | Type |
|---|---|---|---|
| Reviva Pharmaceuticals Holdings Inc | RVPH | NASDAQ | Action ordinaire |
| Variation Action | Variation Action% | Cours Dernier | Dernier échange
|
|
|---|---|---|---|---|
| 0,05 | 1,70% | 2,99 | 16:15:22 |
| Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
|---|---|---|---|---|
| 2,96 | 2,91 | 3,0515 | 2,94 |
Actualités Recentes
| Date | Heure | Source | Titre |
|---|---|---|---|
| 16/2/2024 | 22:32 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
| 14/2/2024 | 06:15 | EDGAR2 | Form EFFECT - Notice of Effectiveness |
| 13/2/2024 | 23:00 | EDGAR2 | Form 424B4 - Prospectus [Rule 424(b)(4)] |
| 02/2/2024 | 22:38 | EDGAR2 | Form S-3 - Registration statement under Securities Act of.. |
| 17/11/2023 | 22:05 | EDGAR2 | Form 8-K - Current report |
| 17/11/2023 | 22:03 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 14/11/2023 | 22:12 | EDGAR2 | Form 8-K - Current report |
| 30/10/2023 | 13:20 | EDGAR2 | Form 8-K - Current report |
| 04/10/2023 | 23:03 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 04/10/2023 | 23:02 | EDGAR2 | Form 8-K - Current report |
| 17/8/2023 | 12:30 | EDGAR2 | Form 8-K - Current report |
| 14/8/2023 | 22:16 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 14/8/2023 | 22:15 | EDGAR2 | Form 8-K - Current report |
| 24/7/2023 | 22:16 | EDGAR2 | Form 8-K - Current report |
